What Is the PSEN1 Gene and How Does It Cause Early Alzheimer’s?

A clear account of how PSEN1 mutations cause Alzheimer's in your 40s, what onset age a positive result can and cannot predict.

PSEN1 is a gene on chromosome 14 that encodes presenilin 1, the catalytic core of an enzyme complex called γ-secretase. When PSEN1 carries a pathogenic mutation, that enzyme cuts amyloid precursor protein in the wrong place, flooding the brain with longer, stickier amyloid-beta fragments that clump into plaques — and the result is Alzheimer's disease that begins decades earlier than usual, often in a person's 40s or 50s.

PSEN1 mutations are the most common known cause of early-onset Alzheimer's, the form that starts before age 65. They are also rare: the whole single-gene, inherited category accounts for under 5% of Alzheimer's cases. If PSEN1 runs in your family, that distinction matters — the disease behaves differently, the inheritance pattern is predictable, and testing decisions arrive much earlier in life than they do for most families.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What presenilin 1 actually does in the brain

According to MedlinePlus Genetics from the NIH, PSEN1 provides instructions for presenilin 1, which serves as the catalytic subunit of γ-secretase. Think of γ-secretase as a pair of molecular scissors. Its job is to cut longer proteins into shorter peptides, and one of the proteins it cuts is amyloid precursor protein, or APP. Where the scissors cut determines what gets released.

A normally functioning presenilin 1 produces amyloid-beta fragments that the brain clears without much trouble. A defective presenilin 1 shifts the cut site. MedlinePlus describes the consequence directly: the altered enzyme produces excess amyloid-beta and longer versions of the peptide, which aggregate into the plaques found in the brains of people with Alzheimer's. The gene itself does not make plaques — it changes the shape of a routine protein-trimming step, and the plaques follow.

How PSEN1 is inherited, and what one copy means

PSEN1 is one of three genes whose mutations cause early-onset Alzheimer's. The National Institute on Aging's genetics fact sheet names the other two: APP on chromosome 21 and PSEN2 on chromosome 1. All three follow an autosomal dominant pattern. One mutated copy, inherited from one parent, is enough to cause the disease — there is no protective second copy.

In practical terms, each child of a carrier has a 50% chance of inheriting the variant. This is categorically different from the genetics most families hear about. APOE e4, the gene most often discussed in late-onset Alzheimer's, raises risk. PSEN1 is causal, which is why a family history here tends to be visible across generations rather than scattered.

Why PSEN1 dominates early-onset cases but explains little of Alzheimer's overall

Two numbers need to sit side by side. MedlinePlus reports that pathogenic PSEN1 variants account for up to 70% of cases of the inherited, early-onset form — by far the largest share of the three genes. Indiana University's NCRAD genetics overview supplies the other number: the familial single-gene form accounts for under 5% of all Alzheimer's cases.

So PSEN1 is the leading cause of a small category. For the great majority of people with Alzheimer's, no single inherited mutation is driving the disease, and a PSEN1 test would return nothing useful. PSEN1 is also unusually variable. A 2022 review in the *International Journal of Molecular Sciences* notes that more than 300 PSEN1 mutations have been reported — 326 catalogued in the Alzforum mutation database as of 2021 — more pathogenic variants than any other early-onset Alzheimer's gene.

What age at onset really looks like

Onset in a PSEN1 family typically falls in the 40s or 50s, and can come much earlier. The Alzforum PSEN1 mutation database records a mean age at onset of 35 years in the I143T family, and roughly 36 to 40 years in M146V families. But the variant matters, and it matters enormously.

Alzforum's entries show the spread: A positive PSEN1 result therefore does not fix a date. It identifies a trajectory, and the specific variant — plus the ages at which affected relatives developed symptoms — carries far more information than the gene name alone. This is a central reason genetic counseling is not a formality here.

  • **A431E** — reported as fully penetrant
  • **G206A** — some carriers have remained symptom-free into their 90s
  • **A79V** — incomplete penetrance, with onset spanning roughly 55 to 78 years

Brain changes start decades before symptoms

In carriers of dominantly inherited mutations, the biology moves long before anything is noticeable. Bateman and colleagues, publishing in the New England Journal of Medicine in 2012 for the Dominantly Inherited Alzheimer Network, found that cerebrospinal fluid amyloid-beta 42 begins declining about 25 years before expected symptom onset, and amyloid deposition visible on PET imaging about 15 years before. A 30-year-old carrier from a family with onset in the mid-50s may already show measurable changes.

That is unsettling to read, and it is also the single most actionable fact about PSEN1. Because onset is predictable within a family and biomarkers shift so early, carriers can be studied and treated before symptoms appear. The DIAN-TU trial network enrolls mutation carriers in prevention trials of disease-modifying drugs on exactly that logic, as set out in its protocol registered on ClinicalTrials.gov under NCT06424236.

Practical steps if PSEN1 is in your family

One detail worth carrying into that first appointment: a mutation in an affected relative must usually be identified before predictive testing in an unaffected family member is informative. If no relative has been tested, that sequencing is the starting point.

  • **Build the family history first.** Ages at symptom onset, not just diagnoses, across as many relatives as you can document. This is what a genetics specialist will ask for, and it frames every other decision.
  • **Start with genetic counseling, not a test.** The NIA advises genetic counseling alongside any testing. A counselor covers what a result does and does not predict, insurance and employment implications, and who else in the family the result touches.
  • **Ask which variant, if a relative has already tested positive.** Given the range between A431E and G206A, the specific variant changes what the result means.
  • **Ask about research participation.** DIAN and DIAN-TU exist for families like this, and enrollment is open to carriers before symptoms begin.
  • **Treat "I don't want to know" as a legitimate choice.** Predictive testing in an autosomal dominant condition is permanent information, and declining it is a recognized option counselors are trained to support.

Frequently Asked Questions

Does a PSEN1 mutation guarantee I will develop Alzheimer's?

For most variants, yes — PSEN1 is causal rather than risk-raising, and A431E is reported as fully penetrant. But penetrance is not uniform: Alzforum documents G206A carriers who stayed symptom-free into their 90s and incomplete penetrance for A79V.

Is PSEN1 the same as the APOE gene I've read about?

No. APOE e4 raises the risk of late-onset Alzheimer's without causing it. PSEN1, APP and PSEN2 cause early-onset disease directly, in an autosomal dominant pattern.

Should I get a direct-to-consumer genetic test for this?

PSEN1 is not what consumer panels are built around, and a result here reshapes decisions for an entire family. The NIA advises pairing any testing with genetic counseling, which consumer services do not provide.

My parent developed Alzheimer's at 58. Does that mean we carry one of these genes?

Not necessarily. Onset before 65 defines early-onset Alzheimer's, but the single-gene familial form accounts for under 5% of all cases. A clinical genetics evaluation is what distinguishes the two.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.